Erstellt von Livvi Harris
vor mehr als 10 Jahre
|
||
Fostamatinib
R343
Rilonacept
Anakinra
Pralnacasan
Verciniron
Marimastat
NFkB inhibitors for TNFa
Ertanercept
Rituximab
MEDI-155
Zieluton
Infliximab
Adalimumab
certolizumab pegol
PEGylation
Drawbacks of immunotherapy for TNFa
Onercept
Ruxolitinib
Tofacitinib
nedocromil
prednisolone
budsonide
Altrakincept
Pitrakinra
Librikizumab
Ustekinumab
ketotifen
Omalizumab
anti-IL-4
Lebrikizumab
Mepolizumab
Braikinumab